Literature DB >> 32309852

Circular RNA expression profile of lung squamous cell carcinoma: identification of potential biomarkers and therapeutic targets.

Yawei Wang1, Haiyan Zhang2, Jian Wang1, Bei Li1, Xiuwen Wang1.   

Abstract

Emerging evidences indicated that exosomal circular RNAs (circRNAs) could serve as diagnostic biomarkers for cancers. However, the expression profiles and clinical significance of circRNAs in lung squamous cell carcinoma (LUSC) remain largely unknown. Herein, we analyzed circRNAs expression profile in six pairs of plasma exosome samples of LUSC patients using high-throughput sequencing. A total of 252 differentially expressed exosomal circRNAs were identified, including 133 up-regulated circRNAs and 119 down-regulated circRNAs. Subsequently, the circRNAs-miRNAs-mRNAs interaction network was built to investigate potential function of circRNAs. Three up-regulated circRNAs (hsa_circ_0014235, hsa_circ_0025580 and hsa_circ_0026403) were implied to participate in cancer-related pathways. QRT-PCR experiment confirmed the up-regulation of hsa_circ_0014235 and hsa_circ_0025580. Finally, clinical studies indicated that hsa_circ_0014235 and hsa_circ_0025580 could serve as novel diagnostic biomarkers for LUSC. Taken together, our study revealed exosomal circRNAs expression profile in LUSC for the first time and showed the important diagnostic potential for circRNAs in LUSC.
© 2020 The Author(s).

Entities:  

Keywords:  LUSC; biomarkers; circRNAs profile; hsa_circ_0014235; hsa_circ_0025580

Year:  2020        PMID: 32309852     DOI: 10.1042/BSR20194512

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  8 in total

1.  Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.

Authors:  Rong Niu; Dong Li; Jian Chen; Wentao Zhao
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

2.  Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data.

Authors:  Xinlu Yuan; Jianjun Diao; Anqing Du; Song Wen; Ligang Zhou; Yangbin Pan
Journal:  J Transl Med       Date:  2020-12-11       Impact factor: 5.531

Review 3.  The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression.

Authors:  Henok D Habtemariam; Henk-Jan Guchelaar
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-19

Review 4.  Emerging function and clinical significance of extracellular vesicle noncoding RNAs in lung cancer.

Authors:  Chan Shan; Yan Liang; Hongjing Cai; Fei Wang; Xinzhe Chen; Qikun Yin; Kun Wang; Yin Wang
Journal:  Mol Ther Oncolytics       Date:  2022-02-20       Impact factor: 7.200

Review 5.  Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer.

Authors:  Chengpeng Sang; Dingyu Rao; Caixia Wu; Yao Xia; Maoyan Si; Zhixian Tang
Journal:  Oncol Lett       Date:  2022-07-07       Impact factor: 3.111

6.  circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.

Authors:  Shan Hu; Peng Cao; Kangle Kong; Peng Han; Jiaqi Yue; Yu Deng; Fan Li; Bo Zhao
Journal:  Dis Markers       Date:  2022-08-16       Impact factor: 3.464

Review 7.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

Review 8.  Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.

Authors:  Jing Wu; Zuojun Shen
Journal:  Cancer Med       Date:  2020-08-10       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.